Lyra Therapeutics, Inc. (LYRA)

NASDAQ: LYRA · IEX Real-Time Price · USD

0.328

-0.004 (-1.09%)

At close: May 31, 2024, 4:00 PM

0.330

+0.002 (0.61%)

After-hours: May 31, 2024, 7:53 PM EDT

Lyra Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-62.68	-55.28	-43.51	-22.13	-16.31	Upgrade
Depreciation & Amortization	0.28	1.07	1	0.1	0.03	Upgrade
Share-Based Compensation	5.89	5.45	2.77	1.81	0.24	Upgrade
Other Operating Activities	-6.79	5.38	13.92	-0.92	2.28	Upgrade
Operating Cash Flow	-63.3	-43.39	-25.82	-21.14	-13.75	Upgrade
Capital Expenditures	-1.05	-0.16	-3.39	-1.78	-0.21	Upgrade
Change in Investments	-11.54	-64.84	0	0	0	Upgrade
Investing Cash Flow	-12.58	-65.01	-3.39	-1.78	-0.21	Upgrade
Share Issuance / Repurchase	69.35	100.5	0.6	57.52	-0.12	Upgrade
Other Financing Activities	-3.65	-4.25	-0.25	30.19	-	Upgrade
Financing Cash Flow	65.69	96.26	0.36	87.7	-0.12	Upgrade
Net Cash Flow	-10.2	-12.13	-28.85	64.79	-14.08	Upgrade
Free Cash Flow	-64.35	-43.55	-29.21	-22.92	-13.97	Upgrade
Free Cash Flow Margin	-4130.36%	-3195.08%	-10247.37%	-	-	Upgrade
Free Cash Flow Per Share	-1.29	-1.44	-2.25	-2.67	-69.10	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).